Aperio Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$1.41M Buy
11,845
+2,069
+21% +$246K ﹤0.01% 1405
2020
Q3
$853K Sell
9,776
-1,470
-13% -$128K ﹤0.01% 1521
2020
Q2
$1.01M Sell
11,246
-1,569
-12% -$140K ﹤0.01% 1407
2020
Q1
$1.28M Buy
12,815
+1,002
+8% +$99.8K 0.01% 1203
2019
Q4
$1.36M Sell
11,813
-1,552
-12% -$178K ﹤0.01% 1277
2019
Q3
$1.69M Buy
13,365
+1,604
+14% +$202K 0.01% 1129
2019
Q2
$1.42M Sell
11,761
-5,420
-32% -$652K 0.01% 1224
2019
Q1
$1.5M Sell
17,181
-3,935
-19% -$344K 0.01% 1169
2018
Q4
$2.11M Buy
21,116
+3,670
+21% +$367K 0.01% 967
2018
Q3
$2M Buy
17,446
+5,579
+47% +$639K 0.01% 1062
2018
Q2
$1.06M Buy
11,867
+269
+2% +$24.1K 0.01% 1345
2018
Q1
$849K Buy
11,598
+213
+2% +$15.6K ﹤0.01% 1419
2017
Q4
$661K Buy
11,385
+715
+7% +$41.5K ﹤0.01% 1565
2017
Q3
$479K Sell
10,670
-25
-0.2% -$1.12K ﹤0.01% 1685
2017
Q2
$422K Buy
10,695
+1,393
+15% +$55K ﹤0.01% 1729
2017
Q1
$377K Sell
9,302
-16
-0.2% -$648 ﹤0.01% 1711
2016
Q4
$375K Buy
9,318
+2,015
+28% +$81.1K ﹤0.01% 1678
2016
Q3
$264K Buy
+7,303
New +$264K ﹤0.01% 1780
2016
Q2
Sell
-8,275
Closed -$289K 2017
2016
Q1
$289K Sell
8,275
-276
-3% -$9.64K ﹤0.01% 1684
2015
Q4
$276K Sell
8,551
-3,900
-31% -$126K ﹤0.01% 1668
2015
Q3
$402K Sell
12,451
-2,447
-16% -$79K ﹤0.01% 1423
2015
Q2
$616K Buy
14,898
+414
+3% +$17.1K 0.01% 1214
2015
Q1
$651K Buy
14,484
+1,244
+9% +$55.9K 0.01% 1132
2014
Q4
$495K Buy
13,240
+3,592
+37% +$134K 0.01% 1232
2014
Q3
$337K Sell
9,648
-39
-0.4% -$1.36K ﹤0.01% 1331
2014
Q2
$342K Buy
+9,687
New +$342K 0.01% 1319